Lupin Share Price Gains 5% on Aug 7, Ranks Among Top Nifty Midcap 150 Gainers

Lupin Limited’s stock was trading at ₹1,944.10 on the NSE at 2:50 PM, marking a sharp intraday gain of ₹92.30 or 4.98% over its previous close of ₹1,851.80. This strong performance placed the stock among the top gainers on the Nifty Midcap 150 index.

The session began with an opening price of ₹1,855.90 and saw the stock climb to an intraday high of ₹1,948.20, with a low of ₹1,855.00. The volume-weighted average price (VWAP) for the day stood at ₹1,917.40.

The surge in share price follows Lupin’s robust quarterly and annual financial results, underscoring sustained positive momentum in the company’s business performance.

Strong Financial Performance in Q1 FY26

For the quarter ended June 2025, Lupin reported:

• Revenue: ₹6,268.34 crore (up from ₹5,600.33 crore in Q1 FY25)
• Net Profit: ₹1,221.46 crore (up from ₹805.54 crore in Q1 FY25)

The numbers indicate a steady improvement in operational performance, supported by strong domestic and international sales.

Robust Annual Growth

For the financial year ending March 2025, Lupin posted:

• Annual Revenue: ₹22,707.90 crore (vs ₹20,010.82 crore in FY24)
• Net Profit: ₹3,306.26 crore (vs ₹1,935.57 crore in FY24)

The year-on-year growth highlights Lupin’s ability to scale its operations and improve profitability, despite broader market challenges.

Lupin had also announced a final dividend of ₹12 per share (600%) on May 14, 2025, with the effective date being July 25, 2025. 

Read More: Trump Urges Lowering Drug Prices; Which Companies Have the Most Exposure?

Conclusion

Lupin’s recent stock performance reflects market response to its improved financial results and shareholder-friendly actions. While these developments point to a period of positive momentum for the company, investors may wish to evaluate broader market conditions and company fundamentals before making any decisions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in securities market are subject to market risks, read all the related documents carefully before investing.